Literature DB >> 28018091

Primary leiomyosarcoma of femur.

Nishit Bhatnagar1, Purushotham Lingaiah1, Anurag Tiwari1, Nidhi Mahajan2, Sumit Arora3, Anil Dhal4.   

Abstract

Primary leiomyosarcoma of the bone is exceedingly rare. In this case, we describe a middle-aged female with a primary leiomyosarcoma of the distal femur. The patient was treated by hip disarticulation. The patient continues to be disease-free at one-year follow-up.

Entities:  

Keywords:  Bone; Disarticulation; Femur; Leiomyosarcoma; Primary

Year:  2016        PMID： 28018091      PMCID： PMC5167449          DOI： 10.1016/j.jcot.2016.02.010

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN： 0976-5662


  7 in total

1.  Primary leiomyosarcoma of bone.

Authors:  D M Evans; N G Sanerkin
Journal:  J Pathol Bacteriol       Date:  1965-07

Review 2.  Primary leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review.

Authors:  C R Antonescu; R A Erlandson; A G Huvos
Journal:  Am J Surg Pathol       Date:  1997-11       Impact factor: 6.394

3.  Leiomyosarcoma of bone. A clinicopathologic, immunohistochemical, and ultrastructural study of five cases.

Authors:  J L Myers; J Arocho; W Bernreuter; W Dunham; M T Mazur
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

Review 4.  Primary leiomyosarcoma of bone.

Authors:  M P Young; A J Freemont
Journal:  Histopathology       Date:  1991-09       Impact factor: 5.087

5.  Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 cases.

Authors:  S Johnson; B Têtu; A G Ayala; S P Chawla
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

6.  Primary leiomyosarcoma of bone: report of eight cases.

Authors:  G Jundt; C Moll; A Nidecker; R Schilt; W Remagen
Journal:  Hum Pathol       Date:  1994-11       Impact factor: 3.466

Review 7.  Primary leiomyosarcoma of extragnathic bone: clinicopathologic features and reevaluation of prognosis.

Authors:  Muyibat A Adelani; Stephen J Schultenover; Ginger E Holt; Justin M M Cates
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.